medigraphic.com
A partir del año 2010, la Revista Oficial del INER cambió a NCT (Neumología y Cirugía de Tórax)

 Ver actualización

2001, Number 4

<< Back Next >>

Rev Inst Nal Enf Resp Mex 2001; 14 (4)

COMMUNICATIONS TO THE EDITOR

Celso García Espinosa

Language: Spanish
References: 75
Page: 249
PDF size: 53.26 Kb.


Text Extraction

No abstract


REFERENCES

  1. Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EM. Biological warfare. A historical perspective. JAMA 1997; 278: 412-417.

  2. Simon JD. Biological terrorism. Preparing to meet the threat. JAMA 1997;278:428-430.

  3. Carbunco. Benenson AS, editor. En: Manual para el control de las enfermedades transmisibles. 17a ed. Washington: Organización Panamericana de la Salud, 1997:33-37.

  4. Brachman PS. Anthrax. In: Evans AS, Feldman HA, editors. Bacterial infections of humans. Epidemiology and control. Nueva York, Londres: Plenum Pub, 1982:60-74.

  5. Smego Ra, Gebrian B, Desmangels G. Cutaneous manifestations of anthrax in rural Haití. Clin Infect Dis 1998;26:97-102.

  6. Doganay M, Bakir M, Dokmetas I. A case of cutaneous anthrax with toxaemic shock. Br J Dermatol 1987;117:659-662.

  7. Kutluk MT, Secmeer G, Kanra G, Celiker A, Aksoyek H. Cutaneous anthrax. Cutis 1987;40:117-118.

  8. Plotkin SA, Brachman PS, Utell M, Bumbord FH, Atchinson MM. An epidemic of inhalation anthrax. The first of the twentieth century. Am J Med 1960;4:992-1001.

  9. Dahlgren ChM, Buchanan LM, Decker HM, Freed SW, Phillips ChR, Brachman PS. Bacillus anthracis aerosols in goat hair processing mills. Am J Hyg 1960;72:24-31.

  10. Brachman P, Plotkin SA, Bumford FH, Atchison MM. An epidemic of inhalation anthrax. The first in the twentieth century II. Epidemiology. Am J Hyg 1960;72:6-23.

  11. Brachman PS. Industrial anthrax. Ann NY Acad Sc 1958;70:574-584.

  12. Brachman PS. Inhalation anthrax. Ann NY Acad Sc 1980;353:83-93.

  13. Ross JM. The pathogenesis of anthrax following the administration of spore by the respiratory route. J Pathol Bacteriol 1957;73:485-495.

  14. Amramova FA, Grinberg LM, Yampolskaya O, Walker DH. Pathology of inhalational anthrax in 42 cases from the Sverlovsk outbreak in 1979. Proc Natl Acad Sci USA 1993; 90:2291-2294.

  15. Tekin A, Bulut N, Unal T. Acute abdomen due to anthrax. Br J Surg 1997;84:813.

  16. Askaray N, Cinaz P, Coskun U, Serbest M, Koksal F. Cutaneous anthrax. Trop Geogr Med 1990;42:168-171.

  17. Dixon TC, Meselson M, Guillemin J, Hanna PC. Anthrax. Medical progress. N Engl J Med 1999;341:814-826.

  18. Institute of Medicine National Research Council. Improuving civilian medical response to chemical and biological terrorist incidents. Washington: National Academy Press, 1998;1-70.

  19. Inglesby TB, Henderson DA, Barlett JG, Ascher MS, Eitzen E, Friedlander AM, et al. Anthrax as a biological weapon. Medical and public health management. JAMA 1999; 281:1735-1745.

  20. Centers for Disease Control and Prevention. Bioterrorism alleging use of anthrax and interim guidelines for management United States 1998. MMWR Morb Mortal Wkly Rep 1999;48:69-74.

  21. Vessal K, Yeganehdoust J, Dutz W, Kohout E. Radiologic changes in inhalation anthrax. Clin Radiol 1975;26:471-474.

  22. Williams RP. Bacillus anthracis and other spore forming bacilli. In: Braude Al, Davis LE, Fierer J, editors. Infectious diseases and medical microbiology. Philadelphia: Saunders, 1986:270-278.

  23. Dragon DC, Rennie RP. The ecology of anthrax spores. Can Vet J 1995;36:295-301.

  24. Thorne CB. Bacillus anthracis. In: Sonenshein AL, Hoch JA, Losick R, editors. Bacillus subtilis and other Gram-positive bacteria. Biochemistry, physiology, and molecular genetics. Washington: Am Society for Microbiology, 1993:113-124.

  25. Turnbull PCB, Kramer JM. Bacillus. In: Ballows A, editor. Manual of clinical microbiology. 5th ed. Washington: Am Society for Microbiology, 1991:296-303.

  26. Penn CC, Klotz SA. Bacillus anthracis and other aerobic spore formers. In: Gorbach SL, Barlett JG, Blacklow NR, editors. Infectious diseases. 2nd ed. Filadelfia: Saunders, 1998;1747-1750.

  27. Parry JM, Turnbull PCB, Gibson JR. A color atlas of Bacillus species. London: Wolfe Medical, 1983:272-279.

  28. Knisely RF. Selective medium for Bacillus anthracis. J Bacteriol 1966;92:784-786.

  29. Guidi-Rontari C, Weber-Levy M, Labroyere E, Mock M. Germination of Bacillus anthracis spores within alveolar macrophages. 1999;31:9-17.

  30. Leppla SH. The anthax toxin complex. In: Alouf J, Freer JH, editors. Sourcebook of bacterial protein toxins. Londres: Academic Press, 1991:277-302.

  31. Leppla SH. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci USA 1982;79:3162-3166.

  32. Leppla SH. Bacillus anthracis calmodulin-dependent adenylate cyclase: Chemical and enzymatic properties and interactions with eukaryotic cells. Adv cyclic nucleotide protein phosphorilation. Res 1984;17:189-198.

  33. O’Brien J, Friedlander A, Dreier T, Ezzel J, Leppla S. Effects of anthrax toxin components on human neutrophils. Infect Immunol 1985;47;306-310.

  34. Hanna PC, Kruskal BA, Ezekowitz Ra, Bloom BR, Collier RJ. Role of macrophage oxidative burs in the action of anthrax lethal toxin activity. Mol Med 1994;1:7-18.

  35. Klimpel KR, Arora N, Leppla SH. Anthrax toxin lethal factor contains a zinc metaloproteasa consensus sequence which is required for lethal toxin activity. Mol Microbiol 1994;13:1093-1100.

  36. Duesbery NS, Webb CP, Leppla SH. Proteolytic inactivation of MAP-kinase by anthrax lethal factor. Science 1998;280:734-737.

  37. Makino SI, Uchida I, Terakado N, Sasakawa C, Yoshikawa M. Molecular characterization and protein analysis of the cap region which is essential for encapsulation in Bacillus anthracis. Mol Microbiol 1988;2:371-376.

  38. Makino S, Sasakawa C, Uchida I, Terakado N, Yoshikawa M. Cloning and Co2 dependent expression of the genetic region for encapsulation from Bacillus anthracis. Mol Microbiol 1988;2:371-376.

  39. Dai Z, Sirard JC, Mock M, Koehler TM. The atxA gene product activates transcription of the anthrax toxin genes and is essential for virulence. Mol Microbiol 1995;16:1171-1181.

  40. Dai Z, Koehler TM. Regulation of anthrax toxin activator gene (atx’A) expression in Bacillus anthracis: Temperature, not CO2 /bicarbonate, affects Atx’A synthesis. Infect Immun 1997;65:2576-2582.

  41. Vietri NJ, Marrero R, Hoover TA, Welkos SL. Identification and characterization of a trans-activator involved in the regulation of encapsulation by Bacillus anthracis. Gene 1995;152:1-9.

  42. Hanna P. Anthrax pathogenesis and host response. Curr Top Microbiol Immunol 1998;225:13-15.

  43. Harrison LH, Ezzel JW, Abshire TG, Kidd S, Kaufmann AF. Evaluation of serological test for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay. J Infect Dis 1989;160:706-710.

  44. Turnbull PC, Doganay M, Lindeque PM, Aygen B, Mc Laughlin J. Serology and anthrax in humans, livestock at Etosha National Park wildlife. Epidemiol Infect 1992; 108:299-313.

  45. Sirisanthana T, Nelson KE, Ezzel JW, Abshire TG. Serological studies of patients with cutaneous and oral-oropharyngeal anthrax from northern Thailand. Am J Trop Med Hyg 1988;39:575-581.

  46. Johson-Winegar A. Comparasion of enzyme-linked immunoabsorbent and indirect hemagglutination assays for determining anthrax antibodies. J Clin Microbiol 1984;20: 357-361.

  47. Shyakhov E, Rubinstein E. Evaluation of the anthraxin skin test for diagnosis of acute and past human anthrax. Eur Clin Microbiol Infect Dis 1996;15:242-245.

  48. Pfisterer RM. Eine Milzbrandepidemie in der Schweiz: Klinische, diagnostische und epidemiologische Aspekte einer weitgehend vergessenen Krankheit. Schweiz Med Wochenschr 1991;121:813-825.

  49. Shyakhov E, Rubinstein E, Novikov I. Anthrax post-vaccinal cell-mediated immununity in humans: Kinetic patterns. Vaccine 1997;15:631-636.

  50. Andersen GL, Simchock JM, Wilson KH. Identification of a region of genetic variability among Bacillus anthracis strains and related species. J Bacteriol 1996;178: 377-384.

  51. Patra G, Sylvestre P, Ramisse V, Therasse J, Guedson JL. Isolation of a specific chromosomic DNA sequence of Bacillus anthracis and its possible use in diagnosis. FEMS Immunol Med Microbiol 1996;15:223-231.

  52. Patra G, Vaissaire J, Weber-Levy M, Lc Doujet C, Mock M. Molecular characterization of Bacillus strains involved in outbreaks of anthrax in France in 1997. J Clin Microbiol 1998;36:3412-3414.

  53. Ramisse V, Patra G, Garrigue H, Guesdon JL, Mock M. Identification and characterization of Bacillus anthracis by multiplex PCR analysis of sequences on plasmids pX01 and pX02 and cromosomal DNA. FEM Microbiol Lett 1996;145:9-16.

  54. Jackson PJ, Hugh-Jones ME, Adair DM. PCR analysis of tissue samples from the 1979 Sverlovsk anthrax victims: the presence of multiple Bacillus anthracis strains in different victims. Proc Natl Acad Sci USA 1998;95:1224-1229.

  55. Keim P, Kalif A, Scupp J. Molecular evolution and diversity in Bacillus anthracis as detected by amplified fragments length polymorphism markers. J Bacteriol 1997;179: 818-824.

  56. Jackson PJ, Walthers EA, Kalif AS. Characterization of the variable number tandem repeats vrrA from different Bacillus anthracis isolates. Appl Environ Microbiol 1997;63: 1400-1405.

  57. Friedlander AM, Welkos SL, Pitt ML. Postexposure prophylaxis against experimental inhalation anthrax. J Infect Dis 1993;167:1239-1243.

  58. Vankurik J. Causes of the failure of antibiotics prophylaxis of inhalation anthrax and clearence of the spore from the lungs. Folia Microbiol (Praga) 1966;11:459-464.

  59. Vaccine agaist anthrax (editorial). BMJ 1965;5464:717-718.

  60. Anthrax vaccine. Med Lett Drug Ther 1998;40:52-53.

  61. Ivins BE, Fellows P, Pitt ML. Efficacy of standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys. Salisbury Med Bull 1996; 87:125-126.

  62. Brachman PS, Gold H, Plotkin SA, Fekery FR, Werrin M, Ingraham NR. Field evaluation of a human anthrax vaccine. Am J Public Health 1962;52:632-645.

  63. Shlyakhov EN, Rubistein E. Human live anthrax vaccine in the former USSR. Vaccine 1994;12:727-730.

  64. Tahernia AC. Treatment of anthrax in children. Arch Dis Children 1967;42:181-182.

  65. Gold H. Treatment of anthrax. Fed Proc 1967;26:1563-1568.

  66. Knudson GB. Treatment of anthrax in man: history and current concepts. Mil Med 1986;15:71-77.

  67. Doust JY, Sarkarzadeh A, Kavoossi K. Corticosteroid in treatment of malignant edema of chest wall and neck (anthrax). Dis Chest 1968;53:773-774.

  68. Hanna PC, Kochi S, Collier RJ. Biochemical and physiological changes induced by anthrax lethal toxin in J 774 macrophage-like cells. Mol Biol Cells 1992;3:1269-1277.

  69. Russel AD. The destruction of bacterial spores. London: Academic Press, 1982:1-310.

  70. Carter A, Deutsch J, Zelicow P. Catastrophic terrorism. Foreing Aff 1998;77:80-95.

  71. Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EM. Biological warfare: a historical perspective. JAMA 1997;278:412-417.

  72. Pile JC, Malone JD, Eitzen EM, Friedlander A. Anthrax as a potential biological warfare agent. Arch Inter Med 1998;158:429-434.

  73. Morse S, McDade J. Recommendation to working with pathogenic bacteria. Methods Enzymol 1994;235:1-26.

  74. Center for Disease Control and Prevention. Bioterrorism alleging use of anthrax and interim guidelines for management-United States, 1998. MMWR Morb Mortal Wkly Rep 1999;48:69-74.

  75. Friedlander A. Anthrax. In: Zajtchuk R, Bellamy RF, editors. Textbook of military medicine. Medical aspects of chemical and biological warfare. Washington: Office of the Surgeon General, US Dept of the Army, 1997:467-478.




2020     |     www.medigraphic.com